Iksuda Therapeutics deepens clinical pipeline through licensing agreement for Her2 antibody drug conjugate programme from LegoChem Biosciences.

By |2022-02-18T11:51:29+00:00January 10th, 2022|News|

Iksuda Therapeutics (Iksuda), the developer of a new generation of antibody drug conjugates (ADCs)

Comments Off on Iksuda Therapeutics deepens clinical pipeline through licensing agreement for Her2 antibody drug conjugate programme from LegoChem Biosciences.

Life science talent specialist RBW Consulting set to expand its thriving operation with new North East office

By |2022-01-06T10:42:07+00:00January 6th, 2022|News|

Life sciences talent and strategic consultancy, RBW Consulting, has today announced the opening of

Comments Off on Life science talent specialist RBW Consulting set to expand its thriving operation with new North East office
Go to Top